The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Kupffer cells, can also be classically and alternatively activated in vitro by inflammatory<br />
cytokines upregulated in the liver after APAP administration. In the present<br />
studies we determined if these cells play a role in the hepatic response to APAP. ECs<br />
were collected from rats 12-72 hr after administration <strong>of</strong> APAP (600 mg/kg, ip)<br />
and analyzed by real time PCR for expression <strong>of</strong> classical and alternative activation<br />
markers. Treatment <strong>of</strong> rats with APAP resulted in a rapid and transient increase in<br />
EC expression <strong>of</strong> inducible nitric oxide synthase, a marker <strong>of</strong> classical activation.<br />
This was followed at 72 hr by EC expression <strong>of</strong> arginase I (ArgI), YM2 and FIZZ1,<br />
markers <strong>of</strong> alternative activation. Co-culture <strong>of</strong> control ECs with hepatocytes pretreated<br />
with 5 mM APAP for 2 hr resulted in increased expression <strong>of</strong> ArgI and mannose<br />
receptor demonstrating that APAP-injured hepatocytes release factors important<br />
in alternative activation <strong>of</strong> ECs. APAP administration to rats also resulted in<br />
hepatocyte expression <strong>of</strong> matrix metalloproteinase-9 (MMP9) and connective tissue<br />
growth factor (CTGF), markers <strong>of</strong> tissue repair, which was most prominent<br />
after 72 hr. Moreover, control hepatocytes co-cultured with alternatively activated<br />
ECs were found to express MMP9 and CTGF. Taken together, these data suggest a<br />
role <strong>of</strong> alternatively activated ECs in liver repair following APAP intoxication.<br />
Supported by NIH grants GM034310, ES004738, CA132624, AR055073,<br />
ES005022.<br />
456 NEGATIVE REGULATION OF CLASSICAL<br />
MACROPHAGE ACTIVATION BY THE STK RECEPTOR<br />
DURING ACETAMINOPHEN-INDUCED<br />
HEPATOTOXICITY.<br />
C. R. Gardner 1 , Y. Liu 1 , P. A. Hankey 2 , J. D. Laskin 3 and D. L. Laskin 1 . 1 Rutgers<br />
University, Piscataway, NJ, 2 Pennsylvania State University, University Park, PA and<br />
3 UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ.<br />
Classically activated macrophages and mediators they release, including reactive nitrogen<br />
species (RNS), play a critical role in the pathogenesis <strong>of</strong> acetaminophen<br />
(APAP)-induced hepatic necrosis. Restricting the activity <strong>of</strong> these macrophages and<br />
production <strong>of</strong> RNS is key to ameliorating tissue injury and initiating wound healing.<br />
Macrophage stimulating protein (MSP) is a liver-derived protein reported to<br />
bind to the STK receptor on macrophages resulting in inhibition <strong>of</strong> NF-κB and<br />
down regulation <strong>of</strong> inducible nitric oxide synthase (iNOS). In the present studies<br />
we analyzed the role <strong>of</strong> MSP signaling via STK in regulating macrophage cytotoxic<br />
activity during APAP-induced hepatotoxicity. APAP administration (600 mg/kg,<br />
i.p.) to rats resulted in a rapid and transient increase in iNOS mRNA expression in<br />
liver macrophages which was evident at 24 hr. At this time, expression <strong>of</strong> the antiinflammatory<br />
cytokine, IL-10 was suppressed. <strong>The</strong>se are characteristics <strong>of</strong> classically<br />
activated cytotoxic macrophages. Treatment <strong>of</strong> animals with APAP also resulted<br />
in increased expression <strong>of</strong> STK in liver macrophages. To analyze the role <strong>of</strong><br />
STK in APAP hepatotoxicity, we used transgenic mice lacking this receptor. We<br />
found that STK-/- mice were significantly more sensitive to APAP than wild type<br />
mice. Thus while administration <strong>of</strong> APAP to wild type mice resulted in 8% mortality<br />
at 24 hr, in STK-/- mice, mortality was 44%. Moreover, surviving STK-/- mice<br />
displayed severe hemorrhagic centrilobular hepatic necrosis with injury extending<br />
into the midzonal and portal regions <strong>of</strong> the liver, which was not evident in wild type<br />
mice. Taken together, these findings suggest that MSP signaling via STK is important<br />
in down regulating inflammatory responses <strong>of</strong> cytotoxic hepatic macrophages<br />
and promoting repair following APAP intoxication. Supported by NIH<br />
GM034310, ES004738, CA132624, AR055073 and ES005022.<br />
457 ROLE OF MACROPHAGE-DERIVED GALECTIN-3 IN<br />
ACETAMINOPHEN-INDUCED HEPATOTOXICITY.<br />
A. Dragomir 1 , R. Sun 1 , J. D. Laskin 2 and D. L. Laskin 1 . 1 Pharmacology and<br />
<strong>Toxicology</strong>, Rutgers University, Piscataway, NJ and 2 Environmental and Occupational<br />
Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ.<br />
Toxic doses <strong>of</strong> acetaminophen (APAP), a widely used analgesic, are known to cause<br />
centrilobular hepatic necrosis. Accumulating evidence suggests that macrophages<br />
and inflammatory mediators they release play a key role in the pathogenic process.<br />
In the present studies, mechanisms regulating macrophage release <strong>of</strong> inflammatory<br />
mediators were investigated. Galectin-3 (Gal-3) is a beta-galactoside binding lectin<br />
secreted by activated macrophages that stimulates production <strong>of</strong> proinflammatory<br />
mediators and reactive oxygen species. Treatment <strong>of</strong> wild-type mice with APAP<br />
(300 mg/kg, i.p.) resulted in a time-dependent increase in Gal-3 expression in the<br />
liver, reaching a maximum after 48-72 hr. Immunohistochemistry indicated that<br />
Gal-3 was predominantly expressed by macrophages infiltrating into necrotic areas.<br />
To analyze the role <strong>of</strong> Gal-3 in APAP-induced hepatotoxicity, we used Gal-3 -/mice.<br />
In wild-type mice, APAP caused a time-dependent increase in serum ALT<br />
and AST levels, beginning within 6 hr. This was associated with histological evidence<br />
<strong>of</strong> centrilobular necrosis. <strong>The</strong>se effects were significantly attenuated in Gal-3 -<br />
/- mice. APAP-induced increases in expression <strong>of</strong> the proinflammatory cytokines<br />
98 SOT 2011 ANNUAL MEETING<br />
TNF-α, and MCP-1, and lipocalin 2, a marker <strong>of</strong> oxidative stress, were also reduced<br />
in Gal-3 -/- mice. In contrast, expression <strong>of</strong> the antioxidant enzyme, heme<br />
oxygenase-1, as well as the anti-inflammatory protein galectin-1, were increased in<br />
Gal-3 -/- mice relative to wild-type mice following APAP administration. Taken together,<br />
these results suggest that Gal-3 plays an important role in macrophage activation<br />
and mediator release during the pathogenesis <strong>of</strong> APAP-induced hepatotoxicity.<br />
Supported by NIH grants GM034310, ES004738, CA132624, AR055073 and<br />
ES005022.<br />
458 TARGETING OF THIOREDOXIN REDUCTASE BY THE<br />
ACETAMINOPHEN METABOLITE N-ACETYL-P-<br />
BENZOQUINONE IMINE.<br />
Y. Jan 1 , D. E. Heck 2 , D. L. Laskin 3 , Y. Liu 3 , A. Dragomir 3 and J. D. Laskin 1 .<br />
1 Environmental & Occupational Medicine, UMDNJ-Robert Wood Johnson Medical<br />
School, Piscataway, NJ, 2 Environmental Health, New York Medical College, Valhalla,<br />
NY and 3 Pharmacology & <strong>Toxicology</strong>, Rutgers University, Piscataway, NJ.<br />
Acetaminophen (APAP), an analgesic and antipyretic, is bioactivated by cytochrome<br />
P450s in hepatocytes to the reactive electrophilic metabolite N-acetyl-pbenzoquinone<br />
imine (NAPQI). NAPQI is known to bind to glutathione and a variety<br />
<strong>of</strong> hepatic proteins, an important downstream event mediating<br />
acetaminophen hepatotoxicity. Mammalian thioredoxin reductase (TrxR) is a critical<br />
cellular antioxidant which contains a selenocysteine in its C-terminal redox center,<br />
an accessible target for electrophilic modification. In the present studies, we determined<br />
if NAPQI targeted TrxR. APAP (0.5-10 mM) was found to cause a<br />
marked inhibition <strong>of</strong> TrxR activity in primary cultures <strong>of</strong> rat hepatocytes, and in reaction<br />
mixes containing liver microsomes or recombinant P450s and purified rat<br />
liver TrxR. To elucidate mechanisms underlying the inhibitory actions <strong>of</strong> APAP on<br />
TrxR, the effects <strong>of</strong> NAPQI on purified TrxR were characterized. Treatment <strong>of</strong> TrxR<br />
with NAPQI was found to inhibit enzyme activity (IC50 = 23 nM). A recombinant<br />
mutant enzyme, in which selenocysteine was replaced with cysteine, was 5000-fold<br />
less sensitive to NAPQI, suggesting that selenocysteine was modified. This is supported<br />
by our findings that alkylation <strong>of</strong> TrxR with biotin-conjugated iodoacetamide,<br />
which selectively reacts with selenol or thiol groups on proteins, was inhibited<br />
by NAPQI. Moreover, LC-MS/MS analysis demonstrated that NAPQI<br />
selectively modified the cysteine and selenocysteine residues in the C-terminal<br />
redox center <strong>of</strong> TrxR. Collectively, these data demonstrate that reactive intermediates<br />
<strong>of</strong> APAP can target TrxR and this may be an important mechanism by which<br />
APAP overdose induces oxidative stress and cellular damage. Supported by NIH<br />
grants GM034310, AR055073, CA093798, CA132624, ES004738, ES005022,<br />
and ES017389.<br />
459 TRIFLUOPERAZINE MEDIATED<br />
HEPATOPROTECTION AND REDUCTION OF HIF-1α<br />
IN ACETAMINOPHEN MEDIATED TOXICITY IN MICE.<br />
S. Chaudhuri 1 , S. S. McCullough 1 , A. Brown 1 , J. A. Hinson 2 and L. P. James 1, 2 .<br />
1 Pediatrics/Clinical Pharmacology, Arkansas Childrens Hospital Research Institute,<br />
Little Rock, AR and 2 Pharmacology and <strong>Toxicology</strong>, University <strong>of</strong> Arkansas for<br />
Medical Sciences, Little Rock, AR.<br />
Mitochondrial permeability transition (MPT) and oxidative stress are proposed<br />
mechanisms for APAP mediated hepatotoxicity. Trifluoperazine (TFP) has been<br />
previously shown to reduce APAP mediated hepatotoxicity (Yamamoto et al, 1990;<br />
Dimova et al., 1995) in vivo. In vitro studies <strong>of</strong> APAP toxicity in freshly isolated hepatocytes<br />
showed that TFP reduced MPT (Reid et al., 2005). We previously reported<br />
the induction <strong>of</strong> HIF-1α in APAP toxicity in mice and have hypothesized<br />
that HIF-1α induction is secondary to MPT associated oxidative stress. Thus we<br />
examined the effect <strong>of</strong> TFP on hepatotoxicity and HIF-1α induction in APAP mediated<br />
hepatotoxicity. B6C3F1 male mice were pretreated with TFP (10 mg/kg)<br />
prior to APAP (200 mg/kg IP). <strong>The</strong> mice were sacrificed at 1, 4 and 24 h. Mean (±<br />
SE) values for ALT were 1786 (± 258) IU/L and 16 (± 2) IU/L for APAP/veh and<br />
APAP/TFP mice at 4 h, respectively (p≤0.05). At 24 h, mean ALT values were<br />
4267 (± 207) IU/L and 3055 (± 928) IU/L for APAP/veh and APAP/TFP mice<br />
(p≤0.05). Histopathological examination <strong>of</strong> liver sections was consistent with the<br />
biochemical data. Hepatic glutathione depletion and hepatic APAP-protein<br />
adducts were comparable in both groups <strong>of</strong> mice at all time points, indicating that<br />
TFP did not affect the metabolism <strong>of</strong> APAP. HIF-1α expression determined by immunoblots<br />
showed that HIF-1α expression was reduced by 45% in APAP/TFP<br />
mice at 1, 4, and 24 h compared to the APAP/veh mice (p≤0.05). <strong>The</strong> data suggest<br />
that TFP reduces toxicity in APAP treated mice and that HIF-1α induction is secondary<br />
to MPT associated oxidative stress.